skip to Main Content

Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance

Lewis CW, Qazi J, Hippe DS, Lachance K, Thomas H, Cook MM, Juhlin I, Singh N, Thuesmunn Z, Takagishi SR, McEvoy A, Doolittle-Amieva C, Bhatia S, Paulson KG, O'Malley RB, Wang CL, Nghiem P

Cancer Med. 2019 Dec 27. doi: 10.1002/cam4.2781.

PMID: 31883234

View on PubMed - View PDF

Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

Bhatia S, Longino NV, Miller NJ, Kulikauskas R, Iyer JG, Ibrani D, Blom A, Byrd DR, Parvathaneni U, Twitty CG, Campbell JS, Le MH, Gargosky S, Pierce RH, Heller R, Daud AI, Nghiem P

Clin Cancer Res. 2019 Oct 3. doi: 10.1158/1078-0432.CCR-19-0972.

PMID: 31582519

View on PubMed - View PDF

Identification of Therapeutic Vulnerabilities in Small Cell Neuroendocrine Prostate Cancer

Corella AN, Cabiliza Ordonio MVA, Coleman I, Lucas JM, Kaipainen A, Nguyen HM, Sondheim D, Brown L, True LD, Lee JK, MacPherson D, Nghiem P, Gulati R, Morrissey C, Corey E, Nelson PS

Clin Cancer Res. 2019 Dec 5. pii: clincanres.0775.2019. doi: 10.1158/1078-0432.CCR-19-0775

PMID: 31806643

View on PubMed - View PDF

Imaging of Merkel Cell Carcinoma: What Imaging Experts Should Know

Akaike G, Akaike T, Fadl SA, Lachance K, Nghiem P, Behnia F

Radiographics. 2019 Nov-Dec;39(7):2069-2084. doi: 10.1148/rg.2019190102.

PMID: 31697628

View on PubMed - View PDF

Less Toxic, More Effective Treatment—A Win-Win for Patients With Merkel Cell Carcinoma

Nghiem P, Park SY

JAMA Dermatol. 2019 Sep 4. doi: 10.1001/jamadermatol.2019.2584.

PMID: 31483436

View on PubMed - View PDF

Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain

Longino NV, Yang J, Iyer JG, Ibrani D, Chow IT, Laing KJ, Campbell VL, Paulson KG, Kulikauskas RM, Church CD, James EA, Nghiem P, Kwok WW, Koelle DM

Cancer Immunol Res. 2019 Oct;7(10):1727-1739. doi: 10.1158/2326-6066.CIR-19-0103.

PMID: 31405946

View on PubMed - View PDF

Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA

Steuten L, Garmo V, Phatak H, Sullivan SD, Nghiem P, Ramsey SD.

Appl Health Econ Health Policy. 2019 Jun 28. doi: 10.1007/s40258-019-00492-5. [Epub ahead of print]

PMID: 31250217

View on PubMed - View PDF

One in a hundred million: Merkel cell carcinoma in pediatric and young adult patients is rare but more likely to present at advanced stages based on US registry data.

Paulson K, Nghiem P

J Am Acad Dermatol. 2019 Jun;80(6):1758-1760. doi: 10.1016/j.jaad.2018.08.021.

PMID: 30165170

View on PubMed - View PDF

Travel burden associated with rare cancers: The example of Merkel cell carcinoma.

Jain R, Menzin J, Lachance K, McBee P, Phatak H, Nghiem PT.

Cancer Med. 2019 May;8(5):2580-2586. doi: 10.1002/cam4.2085. Epub 2019 Apr 5.

PMID: 30950224

View on PubMed - View PDF

Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.

Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Brohl AS, Friedlander PA, Daud A, Kluger HM, Reddy SA, Boulmay BC, Riker AI, Burgess MA, Hanks BA, Olencki T, Margolin K, Lundgren LM, Soni A, Ramchurren N, Church C, Park SY, Shinohara MM, Salim B, Taube JM, Bird SR, Ibrahim N, Fling SP, Homet Moreno B, Sharon E, Cheever MA, Topalian SL.

J Clin Oncol. 2019 Mar 20;37(9):693-702. doi: 10.1200/JCO.18.01896. Epub 2019 Feb 6.

PMID: 30726175

View on PubMed - View PDF

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.

D'Angelo SP, Hunger M, Brohl AS, Nghiem P, Bhatia S, Hamid O, Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbé C, Lewis KD, Linette GP, Milella M, Schlichting M, Hennessy MH, Bharmal M.

Cancer Immunol Immunother. 2019 Apr;68(4):609-618. doi: 10.1007/s00262-018-02295-4. Epub 2019 Feb 5.

PMID: 30721341

View on PubMed - View PDF

Tuberculosis following PD-1 blockade for cancer immunotherapy

Barber DL, Sakai S, Kudchadkar RR, Fling SP, Day TA, Vergara JA, Ashkin D, Cheng JH, Lundgren LM, Raabe VN, Kraft CS, Nieva JJ, Cheever MA, Nghiem PT, Sharon E

Sci Transl Med. 2019 Jan 16;11(475). pii: eaat2702. doi: 10.1126/scitranslmed.aat2702.

PMID: 30651320

View on PubMed - View PDF

Back To Top